MEDICINOVA INC's ticker is MNOV and the CUSIP is 58468P206. A total of 34 filers reported holding MEDICINOVA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,311,417 | -9.1% | 1,105,941 | 0.0% | 2.04% | +5.9% |
| Q2 2023 | $2,543,664 | +6.5% | 1,105,941 | 0.0% | 1.92% | +39.3% |
| Q1 2023 | $2,388,833 | +5.4% | 1,105,941 | 0.0% | 1.38% | +9.3% |
| Q4 2022 | $2,267,179 | -5.5% | 1,105,941 | 0.0% | 1.26% | +27.4% |
| Q3 2022 | $2,400,000 | -14.2% | 1,105,941 | 0.0% | 0.99% | -14.3% |
| Q2 2022 | $2,798,000 | -5.2% | 1,105,941 | 0.0% | 1.16% | +62.0% |
| Q1 2022 | $2,953,000 | -0.4% | 1,105,941 | 0.0% | 0.71% | +7.0% |
| Q4 2021 | $2,964,000 | -29.3% | 1,105,941 | 0.0% | 0.67% | -28.3% |
| Q3 2021 | $4,192,000 | -10.8% | 1,105,941 | 0.0% | 0.93% | +34.0% |
| Q2 2021 | $4,700,000 | -15.8% | 1,105,941 | 0.0% | 0.69% | -20.5% |
| Q1 2021 | $5,585,000 | -4.0% | 1,105,941 | 0.0% | 0.87% | -42.1% |
| Q4 2020 | $5,817,000 | +0.4% | 1,105,941 | 0.0% | 1.51% | -51.0% |
| Q3 2020 | $5,795,000 | -3.3% | 1,105,941 | 0.0% | 3.08% | +4.7% |
| Q2 2020 | $5,994,000 | +45.7% | 1,105,941 | 0.0% | 2.94% | +11.0% |
| Q1 2020 | $4,114,000 | -45.4% | 1,105,941 | -1.0% | 2.65% | -24.6% |
| Q4 2019 | $7,531,000 | -21.1% | 1,117,355 | -4.5% | 3.51% | -40.9% |
| Q3 2019 | $9,539,000 | -15.4% | 1,170,370 | 0.0% | 5.94% | -8.6% |
| Q2 2019 | $11,271,000 | +16.3% | 1,170,370 | 0.0% | 6.50% | +34.7% |
| Q1 2019 | $9,691,000 | -33.7% | 1,170,370 | 0.0% | 4.82% | -17.1% |
| Q4 2018 | $14,618,000 | 0.0% | 1,170,370 | 0.0% | 5.82% | +91.5% |
| Q3 2018 | $14,618,000 | +56.9% | 1,170,370 | 0.0% | 3.04% | +40.5% |
| Q2 2018 | $9,316,000 | -22.1% | 1,170,370 | 0.0% | 2.16% | -17.4% |
| Q1 2018 | $11,961,000 | +58.0% | 1,170,370 | 0.0% | 2.62% | +91.2% |
| Q4 2017 | $7,572,000 | +1.6% | 1,170,370 | 0.0% | 1.37% | +3.5% |
| Q3 2017 | $7,455,000 | +21.1% | 1,170,370 | 0.0% | 1.32% | +18.9% |
| Q2 2017 | $6,156,000 | -12.2% | 1,170,370 | 0.0% | 1.11% | -30.4% |
| Q1 2017 | $7,011,000 | -0.7% | 1,170,370 | 0.0% | 1.60% | -0.6% |
| Q4 2016 | $7,057,000 | -19.5% | 1,170,370 | 0.0% | 1.61% | -11.8% |
| Q3 2016 | $8,766,000 | -0.8% | 1,170,370 | 0.0% | 1.82% | -18.1% |
| Q2 2016 | $8,836,000 | +2.9% | 1,170,370 | 0.0% | 2.23% | -1.0% |
| Q1 2016 | $8,591,000 | +106.8% | 1,170,370 | 0.0% | 2.25% | +195.8% |
| Q4 2015 | $4,155,000 | +26.3% | 1,170,370 | 0.0% | 0.76% | +26.5% |
| Q3 2015 | $3,289,000 | -28.9% | 1,170,370 | 0.0% | 0.60% | -27.9% |
| Q2 2015 | $4,623,000 | +12.9% | 1,170,370 | 0.0% | 0.83% | +2.6% |
| Q1 2015 | $4,096,000 | +15.1% | 1,170,370 | 0.0% | 0.81% | -26.8% |
| Q4 2014 | $3,558,000 | +1.7% | 1,170,370 | 0.0% | 1.11% | -12.9% |
| Q3 2014 | $3,499,000 | +47.3% | 1,170,370 | 0.0% | 1.27% | +157.9% |
| Q2 2014 | $2,376,000 | -1.0% | 1,170,370 | 0.0% | 0.49% | -19.1% |
| Q1 2014 | $2,399,000 | -4.2% | 1,170,370 | 0.0% | 0.61% | -51.5% |
| Q4 2013 | $2,505,000 | -16.7% | 1,170,370 | 0.0% | 1.26% | -36.6% |
| Q3 2013 | $3,007,000 | -2.3% | 1,170,370 | 0.0% | 1.99% | -15.8% |
| Q2 2013 | $3,078,000 | – | 1,170,370 | – | 2.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,105,941 | $2,388,833 | 1.38% |
| Capricorn Fund Managers Ltd | 25,379 | $54,819 | 0.02% |
| Blankinship & Foster, LLC | 15,700 | $33,912 | 0.02% |
| WealthTrust Axiom LLC | 12,500 | $27,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,147 | $313,518 | 0.01% |
| Ergoteles LLC | 69,240 | $149,558 | 0.01% |
| HRT FINANCIAL LP | 163,819 | $353 | 0.00% |
| CITIGROUP INC | 447,957 | $967,587 | 0.00% |
| Tower Research Capital LLC (TRC) | 20,529 | $44 | 0.00% |
| Schonfeld Strategic Advisors LLC | 43,300 | $93,528 | 0.00% |